Cardiac Output Calculator

What Is Cardiac Output?

Cardiac output (CO) is defined as the total volume of blood pumped by the heart per unit of time, most commonly expressed in liters per minute (L/min). It is one of the most fundamental hemodynamic parameters in cardiovascular physiology and clinical medicine. Cardiac output reflects the integrated performance of the heart as a pump and determines how effectively oxygenated blood is delivered to every organ and tissue throughout the body.

Because the cardiovascular system operates as a closed circuit, the output of the left ventricle into the aorta and the output of the right ventricle into the pulmonary artery are essentially equal under steady-state conditions. The left ventricle sends blood through the systemic circulation to supply the entire body, while the right ventricle sends the same volume of blood through the pulmonary circulation for gas exchange in the lungs. Any sustained imbalance between the two sides would quickly result in fluid accumulation in either the pulmonary or systemic venous circuits.

Cardiac output is mathematically the product of two variables: stroke volume (SV), which is the volume of blood ejected from the left ventricle with each heartbeat, and heart rate (HR), which is the number of heartbeats per minute. For a typical healthy adult at rest, stroke volume averages approximately 70 milliliters per beat and resting heart rate is around 70 beats per minute, yielding a cardiac output of approximately 4,900 mL/min, commonly rounded to about 5 L/min. Remarkably, this means the heart pumps a volume roughly equal to the body's entire circulating blood volume every single minute.

The concept of cardiac output was first quantified in the late 19th century and has since become an indispensable tool for understanding cardiovascular health. Whether in the intensive care unit, the operating room, the exercise physiology laboratory, or the outpatient cardiology clinic, cardiac output serves as a critical window into how well the heart is meeting the body's metabolic demands. A resting cardiac output that falls below normal may signal heart failure, hypovolemia, or other serious conditions, while an abnormally elevated cardiac output at rest can indicate hypermetabolic states such as sepsis, anemia, or hyperthyroidism.

Why Cardiac Output Matters

Cardiac output is a direct indicator of how well the heart is fulfilling its primary role: delivering oxygenated blood and nutrients to every cell in the body while simultaneously removing metabolic waste products such as carbon dioxide. When cardiac output is adequate, cells receive enough oxygen to sustain aerobic metabolism, waste products are efficiently cleared, and organ function is maintained. When cardiac output falls below the body's metabolic requirements, a cascade of compensatory mechanisms is triggered, and if those mechanisms fail, tissue hypoxia, organ dysfunction, and ultimately circulatory shock can result.

In the intensive care unit and operating room, cardiac output monitoring is a cornerstone of hemodynamic assessment. Clinicians use it to guide fluid administration, titrate vasoactive medications (such as vasopressors and inotropes), and evaluate the effectiveness of interventions such as mechanical circulatory support devices. In heart failure management, cardiac output measurements help classify disease severity, guide treatment decisions, and determine whether a patient may benefit from advanced therapies like ventricular assist devices or heart transplantation.

The relationship between cardiac output, systemic vascular resistance (SVR), and mean arterial pressure (MAP) is governed by the fundamental hemodynamic equation: MAP = CO × SVR. This means that blood pressure is determined by the interaction between how much blood the heart pumps and the resistance the blood encounters in the vascular system. A change in any one of these variables triggers compensatory adjustments in the others. For example, if cardiac output drops due to acute heart failure, the body compensates by increasing SVR (vasoconstriction) to maintain blood pressure. Understanding cardiac output allows clinicians to identify the underlying cause of hemodynamic instability rather than simply treating a blood pressure number.

Beyond critical care, cardiac output is relevant in exercise physiology, where it increases dramatically during physical activity to supply working muscles with oxygen. It is central to understanding the hemodynamic adaptations of pregnancy, the pathophysiology of anemia and sepsis, and the cardiovascular effects of thyroid disorders. In pharmacology, cardiac output affects drug distribution, organ perfusion, and drug clearance, making it an essential consideration in anesthetic and pharmacological dosing strategies.

The Standard CO Formula (SV × HR) Explained in Detail

The most straightforward and widely used expression for cardiac output is the simple product of stroke volume and heart rate:

Where CO is cardiac output (typically in mL/min, divided by 1,000 to convert to L/min), SV is stroke volume in milliliters per beat, and HR is heart rate in beats per minute. The equation is intuitively logical: if the heart ejects 70 mL of blood with each beat and beats 72 times per minute, then the total volume pumped is 70 × 72 = 5,040 mL/min, or approximately 5.04 L/min.

This formula, while deceptively simple, encapsulates the two fundamental determinants of the heart's pumping performance. Every factor that influences cardiac output ultimately does so by changing either stroke volume, heart rate, or both. During exercise, for example, both SV and HR increase: stroke volume rises due to enhanced venous return and increased contractility (via the Frank-Starling mechanism and sympathetic nervous system stimulation), while heart rate increases through sympathetic activation and parasympathetic withdrawal. The combined effect can raise cardiac output from a resting value of 5 L/min to 20–25 L/min in healthy individuals, and even higher in elite endurance athletes.

Conversely, in pathological conditions like heart failure with reduced ejection fraction (HFrEF), stroke volume is diminished because the weakened ventricle cannot contract forcefully enough to eject a normal volume of blood. The body attempts to compensate by increasing heart rate through sympathetic activation, but this compensation has limits. If heart rate rises too high, diastolic filling time is shortened so severely that ventricular filling is impaired, further reducing stroke volume and potentially worsening the situation in a vicious cycle.

In clinical practice, stroke volume can be estimated noninvasively using echocardiography by measuring the velocity-time integral (VTI) of blood flow through the left ventricular outflow tract (LVOT) and multiplying it by the cross-sectional area of the LVOT. Heart rate is readily available from continuous ECG monitoring or a simple pulse check. The product of these two measurements provides a noninvasive estimate of cardiac output that can be tracked serially to assess treatment response, guide fluid management, or detect hemodynamic deterioration.

Variable	Description	Typical Resting Value
Stroke Volume (SV)	Volume of blood ejected per heartbeat	60–100 mL
Heart Rate (HR)	Number of heartbeats per minute	60–100 bpm
Cardiac Output (CO)	Total blood volume pumped per minute	4.0–8.0 L/min

The Fick Equation Explained in Detail

The Fick principle, first proposed by the German physiologist Adolf Eugen Fick in 1870, provides an alternative and historically foundational method for determining cardiac output. Rather than measuring stroke volume and heart rate directly, the Fick method calculates cardiac output based on the body's rate of oxygen consumption and the difference in oxygen content between arterial and venous blood. The equation is:

Where VO₂ is the rate of whole-body oxygen consumption (in mL/min), CaO₂ is the arterial oxygen content (in mL of O₂ per liter of blood), and CvO₂ is the mixed venous oxygen content (in mL of O₂ per liter of blood). The denominator, CaO₂ − CvO₂, is called the arteriovenous oxygen difference (a-vO₂ difference), and it represents the amount of oxygen extracted by the tissues from each liter of blood that passes through the systemic capillary beds.

The logic behind the Fick principle is elegant and rooted in the conservation of mass. If the body consumes 250 mL of oxygen per minute and each liter of blood passing through the capillaries delivers 50 mL of oxygen to the tissues (the a-vO₂ difference), then the heart must have pumped 250 / 50 = 5.0 liters of blood per minute to supply that amount of oxygen. The total oxygen delivered must equal the total oxygen consumed, and the rate at which blood flows is the bridge between consumption and content difference.

Historical Context

Adolf Fick introduced this principle in a brief communication in 1870, though he never actually performed the measurement himself. It was not until decades later that other researchers validated the method experimentally in animals and humans. Despite its age, the Fick principle remains one of the gold-standard methods for cardiac output determination, particularly during right heart catheterization in the cardiac catheterization laboratory. When oxygen consumption is directly measured (using indirect calorimetry or a metabolic cart), the Fick method provides highly accurate results.

Practical Application

In clinical practice, the Fick method requires three measurements: (1) whole-body oxygen consumption, which can be measured directly using a metabolic cart or estimated from body surface area (approximately 125 mL/min/m² or 3 mL/kg/min); (2) arterial oxygen content, calculated from an arterial blood gas sample using the formula CaO₂ = (1.34 × Hb × SaO₂) + (0.003 × PaO₂), where Hb is hemoglobin concentration, SaO₂ is arterial oxygen saturation, and PaO₂ is partial pressure of dissolved oxygen; and (3) mixed venous oxygen content, obtained from a blood sample drawn from the pulmonary artery via a Swan-Ganz catheter, calculated using the analogous formula CvO₂ = (1.34 × Hb × SvO₂) + (0.003 × PvO₂).

One important limitation of the Fick method is that it assumes a steady state — the patient's oxygen consumption and cardiac output must be relatively stable during the measurement period. In patients with rapidly fluctuating hemodynamics, the Fick calculation may be less reliable. Additionally, using assumed (rather than directly measured) VO₂ values introduces potential error, particularly in critically ill patients whose metabolic rates may differ significantly from population averages due to fever, sepsis, sedation, or mechanical ventilation.

Stroke Volume — What Affects It

Stroke volume (SV) is the volume of blood ejected from the left ventricle with each heartbeat, typically ranging from 60 to 100 mL in a healthy resting adult. It is determined by three primary physiological factors: preload, afterload, and contractility. These three determinants interact dynamically, and changes in any one of them will alter stroke volume and consequently cardiac output.

Preload

Preload refers to the degree of stretch on the ventricular myocardial fibers at the end of diastole, immediately before contraction. It is primarily determined by the volume of blood returning to the heart (venous return) and the compliance (distensibility) of the ventricular wall. According to the Frank-Starling law of the heart, an increase in preload — up to a physiological limit — leads to a more forceful contraction and a greater stroke volume. This intrinsic mechanism allows the heart to automatically adjust its output to match the volume of blood flowing back to it.

Factors that increase preload include increased circulating blood volume (such as from intravenous fluid administration), increased venous tone (sympathetic nervous system activation), the recumbent body position (which increases venous return from the lower extremities), and the skeletal muscle pump during exercise. Factors that decrease preload include hemorrhage, dehydration, positive-pressure mechanical ventilation (which impedes venous return to the right heart), and venodilating drugs like nitroglycerin. Clinically, preload is often assessed by measuring central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), or through echocardiographic assessment of left ventricular end-diastolic volume.

Afterload

Afterload is the resistance or impedance that the ventricle must overcome to eject blood into the arterial system. For the left ventricle, afterload is primarily determined by systemic vascular resistance (SVR), aortic pressure, and the physical properties of the arterial walls (compliance and impedance). An increase in afterload makes it harder for the ventricle to eject blood, which tends to reduce stroke volume and ejection fraction. Conversely, a reduction in afterload facilitates ventricular ejection and increases stroke volume.

Conditions that increase afterload include systemic hypertension, aortic stenosis, and vasoconstriction from sympathetic activation or vasopressor medications. Conditions that reduce afterload include vasodilating drugs (hydralazine, ACE inhibitors, nitroprusside), the vasodilation of sepsis, and arteriovenous fistulas. Afterload reduction is a key therapeutic strategy in heart failure management, as it allows the weakened ventricle to eject more blood with each beat.

Contractility (Inotropy)

Contractility, also called inotropy, refers to the intrinsic ability of the cardiac muscle to generate force during contraction, independent of preload and afterload. Enhanced contractility means the heart can eject a larger fraction of its end-diastolic volume (higher ejection fraction) and achieve a greater stroke volume at any given preload and afterload. Sympathetic nervous system activation and circulating catecholamines (epinephrine, norepinephrine) are the primary physiological enhancers of contractility. Pharmacologically, drugs like dobutamine, milrinone, and digoxin increase contractility.

Conversely, contractility is reduced by myocardial ischemia and infarction, dilated cardiomyopathy, myocarditis, metabolic derangements (acidosis, hypoxia, hyperkalemia), and negative inotropic medications such as beta-blockers and non-dihydropyridine calcium channel blockers. Loss of contractility is the hallmark of systolic heart failure and is the primary reason for reduced stroke volume and cardiac output in these patients.

Factor	Definition	Effect When Increased	Effect When Decreased
Preload	Ventricular wall stretch at end-diastole	Increased SV (Frank-Starling)	Decreased SV
Afterload	Resistance to ventricular ejection	Decreased SV	Increased SV
Contractility	Intrinsic force of contraction	Increased SV	Decreased SV

Heart Rate and Its Relationship to Cardiac Output

Heart rate is the second major determinant of cardiac output and is regulated primarily by the autonomic nervous system. The sinoatrial (SA) node, the heart's intrinsic pacemaker located in the right atrium, generates spontaneous electrical impulses at a rate of approximately 100 beats per minute. However, at rest, the vagus nerve (the primary parasympathetic input to the heart) exerts a dominant inhibitory tone that slows the resting heart rate to 60–80 bpm in most healthy adults.

During physical activity, emotional stress, pain, fever, or other states requiring increased cardiac output, the sympathetic nervous system is activated. Norepinephrine released at the SA node increases the rate of depolarization, while simultaneously, vagal tone is withdrawn. This dual mechanism allows heart rate to increase rapidly, reaching 180–200 bpm or more during maximal exercise in young adults. The maximal heart rate achievable declines with age and is commonly estimated by the formula 220 minus age, though this is only a rough approximation.

Importantly, the relationship between heart rate and cardiac output is not perfectly linear, especially at extreme values. At very high heart rates, the diastolic filling period becomes extremely short. Since the ventricles fill primarily during diastole, a shortened filling time means reduced end-diastolic volume (decreased preload), which in turn decreases stroke volume. Beyond a certain heart rate threshold, the decline in stroke volume outweighs the increase in heart rate, and cardiac output actually begins to fall. This phenomenon is clinically significant in tachyarrhythmias such as atrial fibrillation with rapid ventricular response or supraventricular tachycardia, where rates above 150–170 bpm can cause hemodynamic compromise.

At the other extreme, bradycardia (heart rate below 60 bpm) reduces cardiac output unless stroke volume increases proportionally. In well-trained endurance athletes, resting bradycardia (sometimes below 40 bpm) is a normal finding because their hearts have undergone physiological remodeling, producing a substantially larger stroke volume with each beat that more than compensates for the slower rate. However, pathological bradycardia — caused by atrioventricular block, sick sinus syndrome, or medications like beta-blockers — can lead to dangerously low cardiac output and may require treatment with atropine, isoproterenol, temporary pacing, or permanent pacemaker implantation.

Normal Cardiac Output Values at Rest vs. Exercise

The normal resting cardiac output for an average adult is approximately 4.0 to 8.0 L/min, with a commonly cited average of about 5.0 L/min. This range accommodates natural variation due to body size, age, sex, physical fitness, and metabolic state. Larger individuals have proportionally higher cardiac outputs to perfuse their greater tissue mass, while smaller individuals have proportionally lower values. This is precisely why the cardiac index (CO normalized to body surface area) was developed as a more meaningful comparison metric.

Category	Cardiac Output (L/min)	Interpretation
Low	< 4.0	May indicate heart failure, hypovolemia, or other pathology
Normal (resting)	4.0 – 8.0	Adequate tissue perfusion at rest
Average resting	~5.0	Typical value for a healthy adult
Moderate exercise	10 – 15	Appropriate for moderate physical activity
Intense exercise	20 – 25	Normal for maximal exercise in healthy individuals
Elite athletes (max)	35 – 40	Exceptional cardiac performance during peak effort
High (at rest)	> 8.0	May indicate hypermetabolic state or high-output condition

During exercise, cardiac output increases in direct proportion to the intensity of physical activity. In moderate exercise (such as brisk walking or light cycling), cardiac output may reach 10–15 L/min. During maximal exercise, healthy untrained individuals typically achieve 20–25 L/min, while elite endurance athletes — who have undergone years of cardiovascular training — have been recorded at 35–40 L/min. This extraordinary increase is achieved through both increased heart rate (approaching the age-predicted maximum) and augmented stroke volume (due to enhanced venous return from the muscle pump, increased contractility from sympathetic stimulation, and reduced systemic vascular resistance in exercising muscle beds).

The ability of the cardiovascular system to increase cardiac output during exercise is a key measure of cardiorespiratory fitness. Maximum cardiac output correlates closely with VO₂max (maximal oxygen consumption), which is the gold-standard metric for aerobic fitness. Individuals with heart disease, particularly heart failure, have a severely limited ability to augment cardiac output during exertion, which manifests as exercise intolerance, dyspnea on exertion, and fatigue — the cardinal symptoms of cardiac insufficiency.

Conditions With Low Cardiac Output

A low cardiac output state occurs when the heart is unable to pump sufficient blood to meet the body's resting or exercise metabolic demands. This can arise from impairment of any of the determinants of cardiac output: reduced preload, increased afterload, diminished contractility, or an inadequately low heart rate. Low cardiac output is a life-threatening condition when severe, as it leads to inadequate tissue perfusion and oxygen delivery. Common conditions associated with low cardiac output include:

• Heart failure with reduced ejection fraction (HFrEF): Dilated cardiomyopathy, ischemic cardiomyopathy, and other conditions that weaken the ventricular muscle reduce contractility and stroke volume, leading to chronically low cardiac output. This is the most common cause of sustained low cardiac output in ambulatory patients.
• Acute myocardial infarction: Sudden loss of functioning myocardium due to coronary artery occlusion can dramatically reduce stroke volume, particularly if the infarction is large or involves the anterior wall (which accounts for a large proportion of left ventricular mass). Cardiogenic shock occurs when the infarction is severe enough to cause critically low cardiac output despite compensatory mechanisms.
• Cardiac tamponade: Accumulation of fluid (blood, effusion, or pus) in the pericardial space compresses the cardiac chambers, restricting diastolic filling and reducing preload. This causes a progressive decline in stroke volume and cardiac output that can be rapidly fatal without pericardiocentesis or surgical drainage.
• Severe valvular heart disease: Aortic stenosis imposes increased afterload on the left ventricle, while severe mitral regurgitation causes a portion of each stroke volume to flow backward into the left atrium rather than forward into the aorta, reducing effective (forward) cardiac output.
• Hypovolemia: Hemorrhage, severe dehydration, burns, or third-spacing of fluids reduces circulating blood volume and venous return, leading to decreased preload, diminished stroke volume, and low cardiac output. Hypovolemic shock is one of the most common causes of acute circulatory failure in trauma and surgical patients.
• Tension pneumothorax and massive pulmonary embolism: These conditions obstruct venous return to the heart or right ventricular outflow, respectively, resulting in acutely low cardiac output and cardiovascular collapse.
• Severe bradyarrhythmias: Complete heart block, sinus node dysfunction, or drug-induced bradycardia can reduce cardiac output when the heart rate is too slow for the stroke volume to compensate adequately.

Signs and symptoms of low cardiac output include fatigue, exercise intolerance, cool and clammy extremities (due to compensatory vasoconstriction), altered mental status (from cerebral hypoperfusion), oliguria (low urine output due to renal hypoperfusion), tachycardia (a compensatory response), and in severe cases, frank cardiogenic shock with hypotension, lactic acidosis, and multi-organ dysfunction.

Conditions With High Cardiac Output

While most clinical attention focuses on states of low cardiac output, there are several important conditions in which cardiac output is abnormally elevated at rest. In these high-output states, the heart is pumping more blood than typical because the body's metabolic demands are increased or because systemic vascular resistance is abnormally low, requiring the heart to pump a greater volume to maintain adequate blood pressure. Conditions associated with high cardiac output include:

• Exercise: The most common physiological cause of elevated cardiac output, driven by increased skeletal muscle oxygen demand. This is a normal, healthy response and not pathological.
• Sepsis and systemic inflammatory response: The inflammatory mediators released during sepsis cause widespread vasodilation, dramatically reducing systemic vascular resistance. The heart compensates by increasing cardiac output (the hyperdynamic or high-output phase of sepsis). If the heart cannot sustain this increased workload, septic shock ensues.
• Anemia: When hemoglobin levels are low, each liter of blood carries less oxygen. To maintain adequate oxygen delivery, the heart must pump a greater volume of blood per minute, resulting in increased cardiac output.
• Hyperthyroidism (thyrotoxicosis): Excess thyroid hormones increase the basal metabolic rate of virtually every tissue in the body, driving up oxygen consumption and requiring increased cardiac output. Thyroid hormones also have direct chronotropic (heart rate-increasing) and inotropic (contractility-increasing) effects on the heart.
• Pregnancy: Cardiac output increases by 30–50% during normal pregnancy to support the developing fetus and placenta. This adaptation involves increases in both heart rate and stroke volume, accompanied by a decrease in systemic vascular resistance.
• Arteriovenous fistulas and malformations: Abnormal connections between arteries and veins create low-resistance pathways that reduce effective afterload and increase venous return, leading to elevated cardiac output. This is commonly seen with large surgical AV fistulas created for hemodialysis access.
• Beriberi (thiamine deficiency): Severe thiamine deficiency causes peripheral vasodilation and impaired cellular energy metabolism, leading to high-output heart failure.
• Paget's disease of bone: The increased vascularity of pagetic bone creates additional low-resistance vascular beds that increase total cardiac output.
• Obesity: Increased body mass requires greater blood flow for perfusion, leading to elevated resting cardiac output.

Paradoxically, sustained high-output states can eventually lead to heart failure. This condition, known as high-output heart failure, occurs when the heart can no longer sustain the chronically elevated workload, leading to ventricular dilation, volume overload, and symptoms of congestive heart failure — even though the absolute cardiac output may still be elevated above the normal range. The treatment of high-output heart failure requires addressing the underlying cause (correcting anemia, treating hyperthyroidism, managing sepsis) rather than simply using standard heart failure medications.

How Cardiac Output Is Measured Clinically

Several techniques are available for measuring or estimating cardiac output in clinical practice, spanning a spectrum from highly invasive catheter-based methods to completely noninvasive approaches. The choice of technique depends on the clinical setting, the patient's condition, the degree of accuracy required, and the acceptable level of invasiveness.

Thermodilution (Pulmonary Artery Catheter)

The thermodilution method using a pulmonary artery (Swan-Ganz) catheter has been the clinical reference standard for cardiac output measurement for decades. A known volume of cold saline (typically 10 mL at 0–4°C) is injected rapidly into the right atrium through the proximal port of the catheter. As this cold bolus mixes with blood and flows through the right ventricle and into the pulmonary artery, a thermistor at the catheter tip detects the resulting temperature change over time. The area under the temperature-time curve is inversely proportional to the rate of blood flow (cardiac output), calculated using the modified Stewart-Hamilton equation. Multiple measurements are typically averaged to improve accuracy.

Fick Method

As discussed in detail above, the Fick method calculates cardiac output from oxygen consumption and the arteriovenous oxygen difference. It requires either direct measurement or estimation of VO₂, arterial blood gas analysis for CaO₂, and mixed venous blood sampling from the pulmonary artery for CvO₂. When VO₂ is directly measured, the Fick method is considered the most accurate technique for cardiac output determination.

Echocardiography

Transthoracic echocardiography (TTE) is the most widely used noninvasive method for estimating cardiac output. Using pulsed-wave Doppler, the velocity-time integral (VTI) of blood flow through the left ventricular outflow tract (LVOT) is measured. Stroke volume is then calculated as LVOT VTI multiplied by the cross-sectional area of the LVOT (derived from its diameter). Cardiac output equals SV × HR. Transesophageal echocardiography (TEE) offers superior image quality and is commonly used intraoperatively.

Pulse Contour Analysis

Arterial waveform-based methods (such as PiCCO, FloTrac/Vigileo, LiDCO, and VolumeView) estimate stroke volume beat-by-beat from the morphology of the arterial pressure waveform. These require an arterial catheter and some systems require initial calibration using transpulmonary thermodilution or lithium dilution. They offer the advantage of continuous, real-time cardiac output monitoring.

Esophageal Doppler Monitoring

A miniaturized Doppler transducer placed in the esophagus measures blood flow velocity in the descending thoracic aorta. From this velocity profile, stroke volume and cardiac output can be estimated. This minimally invasive technique is particularly popular in the perioperative setting for goal-directed fluid therapy.

Bioimpedance and Bioreactance

Thoracic bioimpedance and bioreactance are completely noninvasive methods that apply low-amplitude electrical signals across the thorax via surface electrodes. Changes in thoracic impedance (or the phase shift of the signal in bioreactance) with each heartbeat are used to estimate stroke volume and cardiac output. While convenient and risk-free, these methods are generally considered less accurate than invasive techniques and are most useful for trending rather than absolute values.

Method	Invasiveness	Accuracy	Common Setting
Thermodilution (PAC)	Invasive	High (reference standard)	ICU, cardiac catheterization lab
Fick method	Invasive	Very high (with direct VO₂)	Cardiac catheterization lab
Echocardiography	Noninvasive	Good	Bedside, outpatient, OR
Pulse contour analysis	Minimally invasive	Good (with calibration)	ICU, operating room
Esophageal Doppler	Minimally invasive	Moderate–good	Operating room
Bioimpedance/Bioreactance	Noninvasive	Moderate	Bedside, outpatient

Cardiac Output vs. Cardiac Index

While cardiac output provides an absolute measure of the heart's pumping performance in liters per minute, it does not account for differences in body size. A cardiac output of 5.0 L/min might be perfectly normal for a 60 kg woman but potentially insufficient for a 110 kg man with significantly greater metabolic demands. To address this limitation, clinicians routinely use the cardiac index (CI), which normalizes cardiac output to body surface area (BSA):

Body surface area is most commonly calculated using the Du Bois formula: BSA = 0.007184 × Height (cm)^0.725 × Weight (kg)^0.425. For an average adult with a BSA of approximately 1.7–2.0 m², the normal resting cardiac index falls within the range of 2.5 to 4.0 L/min/m².

A cardiac index below 2.2 L/min/m² is generally considered indicative of a clinically significant low-output state. When the cardiac index falls below 1.8 L/min/m² in the presence of elevated filling pressures and signs of tissue hypoperfusion, the patient is in cardiogenic shock. These thresholds are used extensively in the management of acute heart failure and in the evaluation of patients for advanced heart failure therapies.

Parameter	Normal Range	Unit
Cardiac Output (CO)	4.0 – 8.0	L/min
Cardiac Index (CI)	2.5 – 4.0	L/min/m²
Stroke Volume (SV)	60 – 100	mL/beat
Stroke Volume Index (SVI)	33 – 47	mL/beat/m²
Heart Rate (HR)	60 – 100	bpm
Systemic Vascular Resistance (SVR)	800 – 1,200	dynes·s/cm⁵
Mean Arterial Pressure (MAP)	70 – 105	mmHg

Cardiac Output During Pregnancy

Pregnancy induces profound cardiovascular adaptations to support the metabolic demands of the growing fetus, the placenta, and the expanded maternal tissues. One of the most significant of these adaptations is a substantial increase in cardiac output, which begins as early as the first trimester, peaks during the late second and early third trimesters, and returns toward pre-pregnancy levels in the weeks following delivery.

Overall, cardiac output increases by approximately 30–50% above pre-pregnancy values, reaching a peak of approximately 6–7 L/min in most healthy pregnant women (compared to roughly 5 L/min before pregnancy). This increase is achieved through two mechanisms: an increase in heart rate (which rises by approximately 10–20 bpm above the pre-pregnancy baseline) and an increase in stroke volume (which rises by approximately 20–30% due to expanded blood volume and reduced systemic vascular resistance).

The reduction in systemic vascular resistance (SVR) during pregnancy is one of the earliest and most important hemodynamic changes. It is mediated by the vasodilatory effects of hormones such as progesterone, relaxin, and nitric oxide, as well as by the development of the low-resistance uteroplacental circulation. Despite the increase in cardiac output, mean arterial pressure typically decreases slightly during the first and second trimesters due to this vasodilation, before returning toward normal in the third trimester.

During labor and delivery, cardiac output increases even further — by an additional 15–25% above late third-trimester values — due to pain, anxiety, uterine contractions (which squeeze blood from the uterus back into the central circulation), and the increase in circulating catecholamines. Immediately after delivery, autotransfusion from the contracted uterus causes a transient further rise in cardiac output. These dramatic hemodynamic swings during labor and the immediate postpartum period are the reason that women with underlying heart disease are at highest risk for cardiovascular complications during this time.

Trimester / Period	Cardiac Output Change	Primary Mechanism
First trimester (weeks 1–12)	+15–20% above baseline	Decreased SVR, increased blood volume
Second trimester (weeks 13–27)	+30–40% above baseline	Increased SV, increased HR, decreased SVR
Third trimester (weeks 28–40)	+30–50% above baseline (peak)	Maximal blood volume expansion, increased HR
Labor and delivery	Additional +15–25%	Pain, contractions, catecholamines
Immediately postpartum	Transient further increase	Autotransfusion from uterus
6–12 weeks postpartum	Returns to pre-pregnancy levels	Resolution of hormonal and volume changes

Women with pre-existing cardiac conditions — such as valvular heart disease, cardiomyopathy, congenital heart disease, or pulmonary hypertension — may not be able to accommodate these hemodynamic demands of pregnancy, putting them at risk for heart failure, arrhythmias, and other serious complications. Preconception counseling and close cardiac monitoring throughout pregnancy are essential for these patients.

Frequently Asked Questions